Lumexa Imaging director granted 19,358 RSUs

Karlin Bridget E reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Karlin Bridget E reported acquisition or exercise transactions in this Form 4 filing.

Lumexa Imaging Holdings, Inc. director Bridget E. Karlin received an equity grant of 19,358 restricted stock units (RSUs), each representing one share of common stock. The award was granted at no cash cost per unit and is a form of stock-based compensation rather than an open-market purchase.

The RSUs will vest on the earlier of one year from the grant date or the next annual stockholder meeting, provided she continues serving the company. Following this grant, her reported direct holding related to this award is 19,358 shares/RSUs, aligning her compensation more closely with shareholder value.

Insider Trade Summary

Grant/Award: 19,358 shares

Grant/Award 1 txn

Insider Karlin Bridget E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	19,358	$0.00	$0.00

Holdings After Transaction: Common Stock — 19,358 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 19,358 units Grant price per RSU: $0.0000 per unit Holdings after transaction: 19,358 shares/RSUs

3 metrics

RSUs granted 19,358 units Equity award of restricted stock units to director

Grant price per RSU $0.0000 per unit Indicates no cash paid by director for award

Holdings after transaction 19,358 shares/RSUs Total reported direct position following grant

Key Terms

restricted stock units ("RSUs"), contingent right, vest, annual meeting of the Issuer's stockholders

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"each one of which represents the contingent right to receive one share of the Issuer's common stock"

vest financial

"The RSUs will vest on the earlier of the one-year anniversary of the grant date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of the Issuer's stockholders financial

"the next annual meeting of the Issuer's stockholders following the grant date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lumexa Imaging (LMRI) director Bridget E. Karlin receive in this Form 4?

Bridget E. Karlin received a grant of 19,358 restricted stock units (RSUs). Each RSU represents the right to receive one share of Lumexa Imaging common stock, providing stock-based compensation instead of cash and tying part of her pay to the company’s future performance.

Is the Lumexa Imaging (LMRI) Form 4 transaction a stock purchase or a grant?

The Form 4 reflects a grant of RSUs, not a market purchase. The transaction code “A” and zero price per share indicate a compensation-related award, where the director acquires a contingent right to shares rather than buying stock in the open market.

How many Lumexa Imaging (LMRI) RSUs were granted and at what price?

The director was granted 19,358 RSUs at a stated price of $0.0000 per share. This means she did not pay cash for the award; instead, it is stock-based compensation that may convert into common shares upon vesting under the award’s terms.

When do the RSUs reported for Lumexa Imaging (LMRI) vest?

The RSUs vest on the earlier of one year after the grant date or the next annual stockholder meeting. Vesting is conditioned on the director’s continued service with Lumexa Imaging, so leaving the board before that time could affect how many units ultimately vest.

How many Lumexa Imaging (LMRI) shares/RSUs does the director hold after this grant?

After this grant, the Form 4 reports 19,358 shares/RSUs directly associated with the director. This figure reflects her position following the reported transaction and shows the equity stake tied to this specific award, aligning her interests with Lumexa Imaging shareholders.

What does a restricted stock unit (RSU) mean for Lumexa Imaging (LMRI) insiders?

An RSU is a promise to deliver a share of common stock in the future if conditions are met. For Lumexa Imaging insiders, RSUs link compensation to company performance and tenure, because units typically vest over time or at key corporate milestones like annual meetings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Karlin Bridget E

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NORTH CAROLINA 27609

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		19,358(1)	A	$0	19,358	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Paul Gilbert, attorney-in-fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)